2007
DOI: 10.4164/sptj.44.453
|View full text |Cite
|
Sign up to set email alerts
|

New Particle Design and Its Preparation of NFkB Decoy Oligodeoxynucleotide (NDON) Loaded PLGA Nanospheres for Gene Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Bare nanoparticles were redispersed in purified water, and the suspension was mixed with equivalent amounts of 0.05 w/v CS solution. Then, CS-coated nanoparticles were obtained 19,20 .…”
Section: Preparation Of O-carborane-loaded Plga Nanopar-mentioning
confidence: 99%
“…Bare nanoparticles were redispersed in purified water, and the suspension was mixed with equivalent amounts of 0.05 w/v CS solution. Then, CS-coated nanoparticles were obtained 19,20 .…”
Section: Preparation Of O-carborane-loaded Plga Nanopar-mentioning
confidence: 99%
“…At this time, the external PVA phase is adsorbed onto the surface of the emulsion droplets and prevents the coalescence of emulsion droplets. This principle makes this method suitable for the production of ~200-nm-sized drug-loaded PLGA nanospheres, with a uniform particle size distribution, and it has been researched extensively as a new drug delivery system (DDS) technology (Kimura et al, 2008;Nakano et al, 2009;Hara et al, 2008;Tsujimoto et al, 2007a;2007b).…”
Section: Introductionmentioning
confidence: 99%
“…In this study, the ESD method was scaled (crystallizer size, 100 L) at the Pharmaceutical/Beauty Science Research Center of the Hosokawa Micron Corporation. The following steps were completed: (1) mass production of PLGA nanospheres loaded with useful ingredients for cosmetics and quasi-drugs (Charlesworth et al, 1960), and manufacturing and sale of unique skincare products and hair growth formulas containing these PLGA nanospheres; (2) development of a Good Manufacturing Practice (GMP) production method (Tsujimoto et al, 2004;2007b) for ~80-nm-sized PLGA nanospheres that can undergo sterile pressure filtration (Tsukada et al, 2009), for use in injectable pharmaceutical formulations. The study developed a production method for the practical use of PLGA nanospheres.…”
Section: Introductionmentioning
confidence: 99%